PX-1 (also known as 5F-APP-PICA and SRF-30) is an indole-based synthetic cannabinoid that has been sold online as a designer drug.[1][2][3]

Legality

Sweden's public health agency suggested classifying PX-1 as hazardous substance on November 10, 2014.[4]

PX-1 is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.[5]

See also

References

  1. ^ "PX 1". Cayman Chemical. Retrieved 15 July 2015.
  2. ^ Presley BC, Logan BK, Jansen-Varnum SA (March 2020). "Phase I metabolism of synthetic cannabinoid receptor agonist PX-1 (5F-APP-PICA) via incubation with human liver microsomes and UHPLC-HRMS". Biomedical Chromatography. 34 (3): e4786. doi:10.1002/bmc.4786. PMID 31863591. S2CID 209435138.
  3. ^ Dahm P, Thomas A, Rothschild MA, Thevis M, Mercer-Chalmers-Bender K (July 2022). "Phase I-metabolism studies of the synthetic cannabinoids PX-1 and PX-2 using three different in vitro models". Forensic Toxicology. 40 (2): 244–262. doi:10.1007/s11419-021-00606-6. PMC 9715525. PMID 36454402. S2CID 245540105.
  4. ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara" [Cannabinoids are proposed to be classified as dangerous to health] (in Swedish). Folkhälsomyndigheten. Retrieved 16 July 2015.
  5. ^ "Misuse of Drugs Act". Singapore Government. 30 April 2015. Retrieved 24 July 2015.
Allikas: https://en.wikipedia.org/wiki/PX-1
No tags for this post.